Neumora Therapeutics Inc (NASDAQ: NMRA) Is Getting Increasingly Hard To Ignore
Currently, there are 160.48M common shares owned by the public and among those 55.17M shares have been available to trade. The company’s stock has a 5-day price change of -78.11% and -83.20% over the past three months. NMRA shares are trading -76.60% year to date (YTD), with the 12-month market performance down to -84.87% lower. […]
Assessing Whether Neumora Therapeutics Inc (NASDAQ: NMRA) Is Over- Or Undervalued
Neumora Therapeutics Inc (NMRA) concluded trading on Thursday at a closing price of $1.97, with 44.42 million shares of worth about $87.5 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -79.82% during that period and on Thursday the price saw a loss of […]
